scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039936042 |
P356 | DOI | 10.1007/S13277-014-2543-3 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s13277-014-2543-3 |
P698 | PubMed publication ID | 25260882 |
P2093 | author name string | Jun Tang | |
Jun-Gang Zhao | |||
Kai-Ming Ren | |||
P2860 | cites work | Targeting cellular metabolism to improve cancer therapeutics | Q24596727 |
Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer | Q24652941 | ||
5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors | Q28281237 | ||
Combination of sulindac and dichloroacetate kills cancer cells via oxidative damage | Q28481378 | ||
Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells | Q33212894 | ||
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target | Q34310486 | ||
Molecular mechanisms of drug resistance | Q34382998 | ||
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer | Q34595323 | ||
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review | Q34788267 | ||
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. | Q35085558 | ||
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism | Q37002755 | ||
5-Fluorouracil: mechanisms of resistance and reversal strategies | Q37270356 | ||
Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. | Q37653797 | ||
Molecular mechanisms of cisplatin resistance | Q37926477 | ||
Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer | Q39672706 | ||
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice | Q39699461 | ||
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo | Q39835139 | ||
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia | Q40244028 | ||
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. | Q40582817 | ||
Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status | Q43938032 | ||
Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes | Q44077436 | ||
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo | Q44732835 | ||
Screening for dihydropyrimidine dehydrogenase deficiency | Q46610591 | ||
Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil | Q74648273 | ||
P433 | issue | 12 | |
P921 | main subject | cisplatin | Q412415 |
P304 | page(s) | 12305-12315 | |
P577 | publication date | 2014-09-27 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism | |
P478 | volume | 35 |
Q59462482 | 5-Fluorouracil Loaded Chitosan-PVA/NaMMT Nanocomposite Films for Drug Release and Antimicrobial Activity |
Q36958403 | Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin β5-mediated glycolysis |
Q92441132 | Scaffold-based lung tumor culture on porous PLGA microparticle substrates |
Q38903756 | Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells |
Q38762901 | Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer |
Search more.